What is Insulinoma Enucleation?
Insulinoma enucleation is a specialized surgical procedure to remove small, benign insulin-producing tumors in the pancreas. These tumors cause excessive insulin release, leading to dangerously low blood sugar levels (hypoglycemia). By carefully isolating and removing the tumor without removing large portions of the pancreas, surgeons preserve pancreatic function while correcting hormone imbalance. This surgery is typically curative and allows patients to return to normal blood sugar regulation.
This procedure helps to:
- Remove insulin-secreting tumors.
- Correct severe low blood sugar symptoms.
- Prevent long-term complications of hypoglycemia.
- Preserve pancreatic tissue and function.
- Improve quality of life and metabolic health.
What to expect after Insulinoma Enucleation?
The procedure is done under general anesthesia, often laparoscopically. Patients may stay in the hospital for a few days for blood sugar monitoring. After recovery, most experience immediate relief from hypoglycemia and return to normal activities within 2–4 weeks.
- Monitoring of blood sugar levels immediately after surgery.
- Mild abdominal pain or discomfort.
- Gradual resumption of eating and activity.
- Hospital stay of 3–5 days on average.
- Long-term stabilization of glucose control.
